Survival and Side Effects in Non-Small Cell Lung Cancer Patients Treated With Combination of Chemotherapy and Conformal Radiotherapy

BACKGROUND: Combined modality therapy is standard of care for patients with inoperable locally advanced non-small cell lung cancer (NSCLC), however, insufficient data exist regarding what chemoradiotherapy combination will be the gold standard. AIM: The study aimed to compare the survival impact and...

Descripción completa

Detalles Bibliográficos
Autor principal: Crvenkova, Simonida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Republic of Macedonia 2018
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311484/
https://www.ncbi.nlm.nih.gov/pubmed/30607184
http://dx.doi.org/10.3889/oamjms.2018.490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311484/
https://www.ncbi.nlm.nih.gov/pubmed/30607184
http://dx.doi.org/10.3889/oamjms.2018.490

Ejemplares similares